| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eff62ce3dfc6a98a8b590930047db73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e5af37bd49683d69074a86221b935cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e10f8e05fca42dd2a8512fcd14fcad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e1912d863e62f8903f075c82187b10f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a28f656768487caf0a48d6822d6c99f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e31ae1e44cfa24e3cf2560d11243296e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-065 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 |
| filingDate |
2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a5d7e896cf2e6be4e420b831a515632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9919906ce773fff93188166bd6be0a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d196ea419036e449fbf82857ee85178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db9550608b1763a7da0bcbbe4fec5b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c61a31d49b4be954f3751f0dd07faba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf643d345eba142a0fa1f36c885a0f8c |
| publicationDate |
2022-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022409855-A1 |
| titleOfInvention |
Methods of delivering cells and therapeutic agents to organs and extravascular sites |
| abstract |
Methods of delivering cells and other therapeutic agents to organs and extravascular sites using an endoluminal delivery device are provided that allow for retention of the cells or agents at the delivery site at significantly improved levels as compared to needle delivery. Optimal delivery rates using the endoluminal delivery device are also provided. The methods allow for delivery of a variety of therapeutic agents to organs including heart, kidney and pancreas. |
| priorityDate |
2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |